Press Releases

All Releases

Summary Toggle ICU Medical, Inc. Announces Third Quarter 2018 Results

Nov 8, 2018

Company Modifies FY 2018 Guidance and Provides Initial FY 2019 Adjusted EBITDA Guidance SAN CLEMENTE, Calif. , Nov. 08, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical

PDF Version
Summary Toggle ICU Medical, Inc. Announces Time of Third Quarter 2018 Earnings Conference Call

Oct 22, 2018

SAN CLEMENTE, Calif. , Oct. 22, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its third quarter 2018 earnings release and

PDF Version
Summary Toggle ICU Medical, Inc. to Present at the 2018 Morgan Stanley Global Healthcare Conference

Sep 10, 2018

SAN CLEMENTE, Calif. , Sept. 10, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the 2018

PDF Version
Summary Toggle ICU Medical, Inc. Announces Second Quarter 2018 Results

Aug 9, 2018

Company Updates FY 2018 Guidance SAN CLEMENTE, Calif. , Aug. 09, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for

PDF Version
Summary Toggle ICU Medical, Inc. Announces Time of Second Quarter 2018 Earnings Conference Call

Jul 17, 2018

SAN CLEMENTE, Calif. , July 17, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its second quarter 2018 earnings release

PDF Version
Summary Toggle ICU Medical, Inc. Announces First Quarter 2018 Results

May 9, 2018

SAN CLEMENTE, Calif. , May 09, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced financial results for the quarter ended March 31, 2018 .

PDF Version
Summary Toggle ICU Medical, Inc. Announces Time of First Quarter 2018 Earnings Conference Call

Apr 12, 2018

SAN CLEMENTE, Calif. , April 12, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced the time of its first quarter 2018 earnings release

PDF Version
Summary Toggle ICU Medical, Inc. to Present at Raymond James’ 39th Annual Institutional Investors Conference

Mar 2, 2018

SAN CLEMENTE, Calif. , March 02, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced that Company management will present at the Raymond

PDF Version
Summary Toggle ICU Medical, Inc. Announces Fourth Quarter and Fiscal Year 2017 Results

Mar 1, 2018

Company Updates FY 2018 Adjusted EPS Guidance SAN CLEMENTE, Calif. , March 01, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced financial

PDF Version
Summary Toggle ICU Medical, Inc. Announces Time of Fourth Quarter and Fiscal Year 2017 Earnings Conference Call

Feb 5, 2018

SAN CLEMENTE, Calif. , Feb. 05, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced the time of its fourth quarter and fiscal year 2017

PDF Version
Summary Toggle ICU Medical, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference

Dec 18, 2017

SAN CLEMENTE, Calif. , Dec. 18, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced that Company management will present at the 36th Annual

PDF Version
Summary Toggle ICU Medical, Inc. Announces Third Quarter 2017 Results

Nov 9, 2017

Company Updates FY 2017 Guidance and Provides Initial FY 2018 EBITDA and Adjusted EPS Guidance SAN CLEMENTE, Calif. , Nov. 09, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and

PDF Version
Summary Toggle ICU Medical, Inc. Announces Time of Third Quarter 2017 Earnings Call

Oct 12, 2017

SAN CLEMENTE, Calif. , Oct. 12, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced the time of its third quarter 2017 earnings release and

PDF Version
Summary Toggle ICU Medical, Inc. to Participate at the Morgan Stanley 15th Annual Global Healthcare Conference

Aug 17, 2017

SAN CLEMENTE, Calif. , Aug. 17, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced that Company management will participate at

PDF Version
Summary Toggle ICU Medical, Inc. Announces Second Quarter 2017 Results

Aug 9, 2017

SAN CLEMENTE, Calif. , Aug. 09, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced financial results for the quarter ended June 30, 2017 .

PDF Version
Summary Toggle ICU Medical Issues a Voluntary Nationwide Recall of One Lot of 0.9% Sodium Chloride Injection Due to the Presence of Particulate Matter

Jul 28, 2017

LAKE FOREST, Ill. , July 28, 2017 /PRNewswire/ -- ICU Medical, Inc. is voluntarily recalling one lot of 0.9% Sodium Chloride Injection, USP 1000 mL to the hospital/user level due to a confirmed customer complaint of particulate matter identified as stainless steel within a single flexible

PDF Version
Summary Toggle ICU Medical, Inc. Announces Time of Second Quarter 2017 Earnings Call

Jul 11, 2017

SAN CLEMENTE, Calif. , July 11, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced the time of its second quarter 2017 earnings release and

PDF Version
Summary Toggle ICU Medical, Inc. Announces First Quarter 2017 Results

May 10, 2017

SAN CLEMENTE, Calif., May 10, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced financial results for the quarter ended March 31, 2017.

ICU Medical, Inc. Announces First Quarter 2017 Results 48.6 KB
Summary Toggle ICU Medical, Inc. Announces Time of First Quarter 2017 Earnings Call

May 2, 2017

SAN CLEMENTE, Calif., May 02, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced the time of its first quarter 2017 earnings release and

ICU Medical, Inc. Announces Time of First Quarter 2017 Earnings Call 9.7 KB
Summary Toggle ICU Medical, Inc. to Present at the 29th Annual ROTH Conference

Mar 7, 2017

SAN CLEMENTE, Calif., March 07, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced that Company management will present at the

ICU Medical, Inc. to Present at the 29th Annual ROTH Conference 9.8 KB

Infusion Therapy

Oncology

Critical Care

Specialty

Infusion Therapy

Oncology

Critical Care

Support

About Us

Investors

Stock Quote [NASDAQ: ICUI]

Shareholder Tools

All Releases